Abstract
One of the characteristic features of obesity is increased body weight and accumulation of adipose tissue. It is associated with low grade inflammation and gut dysbiosis. Probiotics and its products could be an ideal strategy to prevent or treat diabetes. In the present study, animals were induced obesity by providing them with high fat diet. Three purified bacteriocins i.e., DT24, PJ4 and TSU4, previously isolated and purified from various probiotic strains, were given as treatment strategies, following the induction of obesity. Upon the completion of the study, animals were sacrificed and were checked for their tissue expression of inflammatory mediators and adipokines. Serum hormone and cytokines analysis were performed to check their inflammatory state. Treatment with purified bacteriocin DT24 did not show any therapeutic effect in any of the parameter studied. Bacteriocin TSU4 on the other hand showed better reversal compared to DT24. Bacteriocin PJ4 showed the most promising results by reversing all the altered parameters significantly. It significantly reversed all the biochemical, immunological in terms of serum cytokines as well as altered morphological characteristics. PJ4 can be further explored to determine its mode of action. The anti-microbial proteins or to be more specific, bacteriocins, which shows broad spectrum efficacy, could be a better alternative in modulating gut microflora for the treatment of obesity and diabetes characteristics. The efficacy of bacteriocin PJ4 may also be due to the source of the host of Lactobacillus.
Similar content being viewed by others
References
Alexandraki V, Tsakalidou E, Papadimitriou K, Holzapfel W (2013) Status and trends of the conservation and sustainable use of microorganisms in food processes. FAO 65:160
Ashrafian F, Shahriary A, Behrouzi A, Moradi HR, Raftar SKA, Lari A, Hadifar S, Yaghoubfar R, Badi SA, Khatami S, Vaziri F, Siada SD (2019) Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice. Front Microbiol 10:2155–2172
Balolong MP, Bautista RLS, Ecarma NCA, Balolong EC, Hallare AV, Elegado FB (2017) Evaluating the anti-obesity potential of Lactobacillus fermentum 4B1, a probiotic strain isolated from balao-balao, a traditional Philippine fermented food. Int Food Res J 24(2):819–824
Blüher M (2016) Adipose tissue inflammation: a cause or consequence of obesity related insulin resistance? Clin Sci 130:1603–1614
Cani PD, Jordan BF (2018) Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol 15:671–682
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772
Cani PD, Everard A, Duparc T (2013) Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13:935–940
Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26:26191
Chi H, Holo H (2018) Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin b against gram-positive and gram-negative bacteria. Curr Microbiol 75(3):272–277
Cleusix V, Lacroix C, Vollenweider S, Le Blay G (2008) Glycerol induces reuterin production and decreases escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces. FEMS Microbiol Ecol 63(1):56–64
Devaraj S, Hemarajata P, Versalovic J, Dra Lau L (2013) La microbiota intestinal humana y el metabolismo corporal: Implicaciones con la obesidad y la diabete. Acta Bioquím Clín Latinoam 47(2):421–434
Ejtahed HS, Angoorani P, Soroush AR, Atlasi R, Hasani-Ranjbar S, Mortazavian AM et al (2019) Probiotics supplementation for the obesity management; a systematic review of animal studies and clinical trials. J Funct Foods 52:228–242
Engin A (2017) The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 960:1–17
Ford ES, Williamson DF, Liu S (1997) Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 146:214–222
Frühbeck G, Gomez-Ambrosi J, Bal MJF, Burrell MA (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280:E827–E847
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Ann Rev Immunol 29:415–445
Gross B, Pawlak M, Lefebvre P, Staels B (2017) PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol 13:36–49
Jena PK, Trivedi D, Purandhar K, Chaudhary H, Seshadri S (2011) Antimicrobial Peptides and its Role in Gastro-Intestinal Diseases: a Review. J Animal Sci Adv 1(1):1–11
Jena PK, Trivedi D, Chaudhary H, Sahoo TK, Seshadri S (2013) Bacteriocin PJ4 active against enteric pathogen produced by Lactobacillus helveticus PJ4 isolated from Gut microflora of wistar rat (Rattus norvegicus): Partial purification and characterization of bacteriocin. Appl Biochem Biotechnol 169(7):2088–2100
Kurland AR, Schreiner H, Diamond G (2006) In Vivo Beta-Defensin gene expression in rat gingival epithelium in response to actinobacillus actinomycetemcomitans infection. J Periodontal Res 41(6):567–572
Leung C, Rivera L, Furness JB, Angus PW (2016) The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 13:412–425
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nat 444:1022–1023
Lone JB, Koh WY, Parray HA, Paek WK, Lim J, Rather IA et al (2018) Gut microbiome: Microflora association with obesity and obesity-related comorbidities. Microb Pathog 124:266–271
Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y et al (2002) Diet-induced insulin resistance inmice lacking adiponectin/ACRP30. Nat Med 8:731–737
Nes IF, Yoon S-S, Diep DB (2007) Ribosomally synthesiszed antimicrobial peptides (Bacteriocins) in lactic acid bacteria: A Review. Food Sci Biotechnol 16:675–690
Ng M, Fleming T, Robinson M, Thomson B, Graet N et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945):766–781
Núñez IN, Galdeano CM, de LeBlanc ADM, Perdigón G (2015) Lactobacillus casei CRL 431 administration decreases inflammatory cytokines in a diet-induced obese mouse model. Nutr 31:1000–1007
Panchal SK, Brown L (2011) Rodent models for metabolic syndrome research. J Biomed Biotechnol 2011:351982
Perez-Chanona E, Trinchieri G (2016) The role of microbiota in cancer therapy. Curr Opin Immunol 39:75–81
Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L et al (2017) A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 23:107–113
Qiao Y, Sun J, Xia S, Li L, Li Y, Wang P et al (2015) Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model. J Funct Foods 14:424–434
Resnick HE, Valsania P, Halter JB, Lin X (2000) Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults. J Epidemiol Community Health 54:596–602
Ribeiro CCC, Tabchoury CPM, Cury AADB, Tenuta LMA, Rosalen PL, Cury JA (2005) Effect of starch on the cariogenic potential of sucrose. Br J Nutr 94(1):44–50
Rocha VDS, Claudio ERG, Silva VL, Cordeiro JP, Domingos LF, Cunha MRH (2019) High-Fat Diet-Induced Obesity Model Does Not Promote Endothelial Dysfunction via Increasing Leptin/Akt/eNOS Signaling. Front Physiol 10:268–278
Sahoo TP, Jena PK, Patel AK, Seshadri S (2015) Purification and molecular characterization of the novel highly potent bacteriocin TSU4 produced by lactobacillus animalis TSU4. Appl Biochem Biotechnol 177:90–104
Schneeberger M, Everard A, Gómez-Valadés AG, Matamoros S, Ramírez S, Delzenne NM et al (2015) Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep 5:16643
Seshadri S (2017) Microbial communication via quorum sensing: influence and alteration of gut ecosystem. JSM Biochem Mol Biol 4(1):1020–1023
Silva CCG, Silva SPM, Ribeiro SC (2018) Application of bacteriocins and protective cultures in dairy food preservation. Front Microbiol 9:594. https://doi.org/10.3389/fmicb.2018.00594
Stein CJ, Colditz GA (2004) The epidemic of obesity. J Clin Endocrinol Metab 89:2522–2525
Stienstra R, Duval C, Müller M, Kersten S (2007) PPARs, obesity, and inflammation. PPAR Res 2007:95974
Stienstra R, Tack CJ, Kanneganti TD, Joosten LAB, Netea MG (2012) The inflammasome puts obesity in the danger zone. Cell Metabol 15:10–18
Torres S, Fabersani E, Marquez A, Gauffin-Cano P (2019) Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur J Nutr 58:27–43
Trivedi D, Jena PK, Patel JK, Seshadri S (2013) Partial purification and characterization of a Bacteriocin DT24 produced by Probiotic vaginal Lactobacillus brevis DT24 and determination of its anti-Uropathogenic Escherichia coli potential. Probiotic Antimicrob Proteins 5(2):142–151
Vucenik I, Stains JP (2012) Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci 1271:37–43
Wahli W, Michalik L (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metabol 23:351–363
Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408–415
WHO [World Health Organization] (2017) Obesity and overweight, fact sheet 311.
Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91–100
Zhang J, Lu Y, Wang Y, Ren X, Han J (2018) The impact of the intestinal microbiome on bone health. Intractable Rare Dis Res 7:148–155
Acknowledgement
The authors would like to thank Jinan Central Hospital Affiliated to Shandong University, Jinan, China and Nirma University for financial assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no conflicts of interests to disclose.
Rights and permissions
About this article
Cite this article
Bai, L., Kumar, S., Verma, S. et al. Bacteriocin PJ4 from probiotic lactobacillus reduced adipokine and inflammasome in high fat diet induced obesity. 3 Biotech 10, 355 (2020). https://doi.org/10.1007/s13205-020-02317-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-020-02317-y